Amrize Ltd AMRZ 深 沪
已收盘 09-26 16:00:00 美东时间
47.67
+0.310
+0.65%
华盛通- 最 高47.76
- 今 开47.11
- 成交量 388.34万股
- 最 低 46.88
- 昨 收 47.36
- 总市值 263.62亿
- 52周最高 56.2899
- 市盈率 静 20.68
- 换手率 0.70%
- 52周最低 44.12
- 委 比 -80.68%
- 总股本 5.53亿
- 历史最高 56.2899
- 量 比 0.32
- 振 幅 1.86%
- 历史最低 44.12
- 每 手 1
- 风险率 1.84%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多New Buy Rating for Amrize Ltd (AMRZ), the Basic Materials Giant
Truist Financial analyst Keith Hughes reiterated a Buy rating on Amrize Ltd tod...
09-22 19:15
美股大行评级 | 潜在涨幅577.08%！Veritone获D. Boral Capital升目标价至26美元，维持"买入"评级
今日重点评级关注：D. Boral Capital：维持Veritone"买入"评级，目标价从6美元升至26美元；Guggenheim：维持Dianthus Therapeutics"买入"评级，目标价从92美元升至100美元
09-10 18:01
Oppenheimer Initiates Coverage On Amrize with Outperform Rating, Announces Price Target of $62
Oppenheimer analyst Bryan Blair initiates coverage on Amrize (NYSE:AMRZ) with a Outperform rating and announces Price Target of $62.
09-09 20:18
Alpha Buying: Thin Insider Buying Makes These Recent Purchases Significant
I am still not seeing a lot of meaningful insider or institutional buying activ...
09-04 22:38
Amrize Advises Against TRC Capital’s Mini-Tender Offer
Amrize Ltd ( ($AMRZ) ) just unveiled an update. Amrize Ltd has advised its shar...
08-29 05:03
10 Analysts Assess Amrize: What You Need To Know
Amrize (NYSE:AMRZ) has been analyzed by 10 analysts in the last three months, r...
08-27 03:01
JP Morgan Maintains Overweight on Amrize, Raises Price Target to $60
JP Morgan analyst Adrian Huerta maintains Amrize (NYSE:AMRZ) with a Overweight and raises the price target from $52 to $60.
08-26 23:06
美股大行评级 | 潜在涨幅286.44%！RBC Capital上调Edgewise Therapeutics目标价至49美元，维持"跑赢大市"评级
今日重点评级关注：RBC Capital：维持Edgewise Therapeutics"跑赢大市"评级，目标价从48美元升至49美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从6美元升至7美元
08-11 09:43
